# Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

> **NCT07265739** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 27 (estimated)

## Conditions studied

- Platinum Resistant Ovarian Cancer

## Interventions

- **DRUG:** losartan
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT07265739
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07265739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07265739, "Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07265739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*